Trade MIRM stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Mirum Pharmaceuticals, Inc. (MIRM) is trading at US$96.13, up 0.65% today as of Nov 20, 16:00 EST. The company has a market capitalisation of US$6.29B. Over the past 52 weeks, MIRM has traded between US$63.23 and US$130.00. On Syfe you can trade MIRM with $0 commission and add it to your watchlist.
| Previous close | US$95.51 |
|---|---|
| Market cap | US$6.29B |
| 52-week range | US$63.23 – US$130.00 |
| Volume | 1.04M |
| Exchange | US |
Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products pipeline includes Maralixibat, Cholbam, Ctexli, Volixibat, Brelovitug, MRM-3379, and Zilurgisertib. The company was founded by Niall O'Donnel, Michael G. Grey, and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.
Year: 2019
Mirum Pharmaceuticals, Inc. (MIRM) stock is trading at US$96.13, +0.65% from the previous close of US$95.51.
The market cap for Mirum Pharmaceuticals, Inc. (MIRM) stock is approximately US$6.29B.
The 52-week high for Mirum Pharmaceuticals, Inc. (MIRM) stock is US$130.00.
The 52-week low for Mirum Pharmaceuticals, Inc. (MIRM) stock is US$63.23.
Mirum Pharmaceuticals, Inc. (MIRM) does not currently pay a dividend.
Stay on top of MIRM
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore